BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33665984)

  • 1. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
    Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
    Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
    Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
    Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
    Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
    Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†.
    Sun C; Anraku M; Karasaki T; Kuwano H; Nagayama K; Nitadori JI; Sato M; Nakajima J
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):414-420. PubMed ID: 30289481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403.
    Matsuo Y; Nagata Y; Wakabayashi M; Ishikura S; Onishi H; Kokubo M; Karasawa K; Shioyama Y; Onimaru R; Hiraoka M
    J Radiat Res; 2021 Sep; 62(5):901-909. PubMed ID: 34350956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
    Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.
    Kim EY; Lee HY; Kim KW; Lee JI; Kim YS; Choi WJ; Kim JH
    Scand J Surg; 2018 Sep; 107(3):244-251. PubMed ID: 29284364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative computed tomography-determined quantity and quality of skeletal muscle on survival after resected non-small cell lung carcinoma.
    Çınar HU; Çelik B; Taşkın G; İnce Ö
    Eur J Surg Oncol; 2022 Sep; 48(9):1937-1946. PubMed ID: 35361518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
    Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
    Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
    J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
    Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
    Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis.
    Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
    Support Care Cancer; 2020 Jan; 28(1):389-394. PubMed ID: 31055666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
    PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.
    Bongers MER; Groot OQ; Buckless CG; Kapoor ND; Twining PK; Schwab JH; Torriani M; Bredella MA
    Spine J; 2022 Apr; 22(4):595-604. PubMed ID: 34699994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.